CIK 0001649094 · Large accelerated filer
Vaxcyte, Inc.
Sign in to watch- Ticker
- PCVX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 464233385
- Phone
- 650-837-0111
- Business address
- 825 INDUSTRIAL ROAD, STE. 300, SAN CARLOS, CA, 94070
- Former names
- SutroVax, Inc.
- 8-K Event Regulation FD disclosure · Other events
- 4 Planned sale EVP, Chief Scientific Ofc, COO sold 2,250 shares at an average $56.67 ($127,513)
- 144 Insider Sale of Securities
- 4 Shares withheld for taxes CHIEF EXECUTIVE OFFICER gave up 17,056 shares (to pay taxes)
- 4 Shares withheld for taxes PRESIDENT AND CFO gave up 7,155 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Technical Ops Officer gave up 7,651 shares (to pay taxes)
- 4 Shares withheld for taxes SVP, Finance & CAO gave up 1,327 shares (to pay taxes)
- 4 Open-market sale EVP, Chief Scientific Ofc, COO sold 2,715 shares at an average $60.35 ($163,863)
- 4 Grant or award Chief Medical Officer acquired 52,632 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 8-K Event Executive or director change · Regulation FD disclosure
- 4 Open-market sale CHIEF OPERATING OFFICER sold 3,477 shares at an average $61.07 ($212,352)
- 4 Shares withheld for taxes CHIEF EXECUTIVE OFFICER gave up 6,289 shares (to pay taxes)
- 4 Shares withheld for taxes PRESIDENT AND CFO gave up 2,705 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Technical Ops Officer gave up 1,020 shares (to pay taxes)
- 4 Shares withheld for taxes SVP, Finance & CAO gave up 569 shares (to pay taxes)
- 144 Insider Sale of Securities
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
Page 2 of 39 · 770 filings